Endometriosis-associated pain scores and biomarkers in users of the etonogestrel-releasing subdermal implant or the 52-mg levonorgestrel-releasing intrauterine system for up to 24 months

References

• Vercellini P, Viganò P, Somigliana E, et al. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014;10:261–275.
   PubMed Web of Science ®Google Scholar
• Buck Louis GM, Hediger ML, Peterson CM, et al. Incidence of endometriosis by study population and diagnostic method: the ENDO study. Fertil Steril. 2011;96:360–365.
   PubMed Web of Science ®Google Scholar
• Johnson NP, Hummelshoj L, Adamson GD, et al. World Endometriosis Society consensus on the classification of endometriosis. Hum Reprod. 2017;32:315–324.
   PubMed Web of Science ®Google Scholar
• Donnez J. Introduction: from pathogenesis to therapy, deep endometriosis remains a source of controversy. Fertil Steril. 2017;108:869–871.
   PubMed Web of Science ®Google Scholar
• Dunselman GAJ, Vermeulen N, Becker C, et al. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014;29:400–412.
   PubMed Web of Science ®Google Scholar
• Brown J, Farquhar C. Endometriosis: an overview of Cochrane reviews. Cochrane Database Syst Rev. 2014;3:CD009590.
   PubMed Web of Science ®Google Scholar
• Guo SW. Recurrence of endometriosis and its control. Hum Reprod Update. 2009;15:441–461.
   PubMed Web of Science ®Google Scholar
• Ahn SH, Singh V, Tayade C. Biomarkers in endometriosis: challenges and opportunities. Fertil Steril. 2017;107:523–532.
   PubMed Web of Science ®Google Scholar
• Gupta D, Hull ML, Fraser I, et al. Endometrial biomarkers for the non-invasive diagnosis of endometriosis. Cochrane Database Syst Rev. 2016;4:CD012165
   PubMed Web of Science ®Google Scholar
• Margatho D, Mota Carvalho N, Eloy L, et al. Assessment of biomarkers in women with endometriosis-associated pain using the ENG contraceptive implant or the 52 mg LNG-IUS: a non-inferiority randomised clinical trial. Eur J Contracept Reprod Health Care. 2018;23:344–350.
   PubMed Web of Science ®Google Scholar
• Gonçalves MO, Podgaec S, Dias JA Jr, et al. Transvaginal ultrasonography with bowel preparation is able to predict the number of lesions and rectosigmoid layers affected in cases of deep endometriosis, defining surgical strategy. Hum Reprod. 2010;25:665–671.
   PubMed Web of Science ®Google Scholar
• Chamié LP, Blasbalg R, Gonçalves MO, et al. Accuracy of magnetic resonance imaging for diagnosis and preoperative assessment of deeply infiltrating endometriosis. Int J Gynecol Obstet. 2009;106:198–201.
   PubMed Web of Science ®Google Scholar
• Odukoya O, Bansal A, Cooke I. Serum endometrial IgG antibodies and soluble CD23 concentrations in patients with endometriosis. Acta Obstet Gynecol Scand. 1996;75:927–931.
   PubMed Web of Science ®Google Scholar
• Odukoya O-A, Bansal A, Wilson P, et al. Soluble CD23 protein in the peritoneal fluid of patients with endometriosis. Hum Reprod. 1996;11:2018–2021.
   PubMed Web of Science ®Google Scholar
• Matalliotakis IM, Neonaki MA, Koumantaki YG, et al. A randomized comparison of danazol and leuprolide acetate suppression of serum-soluble CD23 levels in endometriosis. Obstet Gynecol. 2000;95:810–813.
   PubMed Web of Science ®Google Scholar
• Grandi G, Barra F, Ferrero S, et al. Hormonal contraception in women with endometriosis: a systematic review. Eur J Contracept Reprod Health Care. 2019;24:61–70.
   PubMed Web of Science ®Google Scholar
• Carvalho N, Margatho D, Cursino K, et al. Control of endometriosis-associated pain with etonogestrel-releasing contraceptive implant and 52-mg levonorgestrel-releasing intrauterine system: randomized clinical trial. Fertil Steril. 2018;110:1129–1136.
   PubMed Web of Science ®Google Scholar
• Fedele L, Bianchi S, Zanconato G, et al. Use of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis. Fertil Steril. 2001;75:485–488.
   PubMed Web of Science ®Google Scholar
• Petta CA, Ferriani RA, Abrao MS, et al. Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis. Hum Reprod. 2005;20:1993–1998.
   PubMed Web of Science ®Google Scholar
• Walch K, Unfried G, Huber J, et al. Implanon® versus medroxyprogesterone acetate: effects on pain scores in patients with symptomatic endometriosis – a pilot study. Contraception. 2009;79:29–34.
   PubMed Web of Science ®Google Scholar
• Schindler AE, Campagnoli C, Druckmann R, et al. Classification and pharmacology of progestins. Maturitas. 2003;46:7–16.
   PubMed Web of Science ®Google Scholar
• American Society for Reproductive Medicine. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril. 1997;67:817–821.
   PubMed Web of Science ®Google Scholar
• Haas D, Shebl O, Shamiyeh A, et al. The rASRM score and the Enzian classification for endometriosis: their strengths and weaknesses. Acta Obstet Gynecol Scand. 2013;92:3–7.
   PubMed Web of Science ®Google Scholar
• Vercellini P, Aimi G, Panazza S, et al. A levonorgestrel-releasing intrauterine system for the treatment of dysmenorrhea associated with endometriosis: a pilot study. Fertil Steril. 1999;72:505–508.
   PubMed Web of Science ®Google Scholar
• World Health Organization, Department of Reproductive Health and Research. Medical eligibility criteria for contraceptive use. 5th ed. Geneva: WHO; 2015.
   Google Scholar
• Bedaiwy MA, Alfaraj S, Yong P, et al. New developments in the medical treatment of endometriosis. Fertil Steril. 2017;107:555–565.
   PubMed Web of Science ®Google Scholar
• Vandever MA, Kuehl TJ, Sulak PJ, et al. Evaluation of pituitary ovarian axis suppression with three oral contraceptive regimens. Contraception. 2008;77:162–170.
   PubMed Web of Science ®Google Scholar
• Moraes LG, Marchi NM, Pitoli AC, et al. Assessment of the quality of cervical mucus among users of the levonorgestrel-releasing intrauterine system at different times of use. Eur J Contracept Reprod Health Care. 2016;21:318–322.
   PubMed Web of Science ®Google Scholar
• Bahamondes MV, Monteiro I, Castro S, et al. Prospective study of the forearm bone mineral density of long-term users of the levonorgestrel-releasing intrauterine system. Hum Reprod. 2010;25:1158–1164.
   PubMed Web of Science ®Google Scholar
• Beerthuizen R, van Beek A, Massai R, et al. Bone mineral density during long-term use of the progestagen contraceptive implant Implanon compared to a non-hormonal method of contraception. Hum Reprod. 2000;15:118–122.
   PubMed Web of Science ®Google Scholar
• MSD. Implanon (etonogestrel implant) 68 mg for subdermal use only; 2009 [cited 2020 Jan 12]. Available from: www.accessdata.fda.gov/drugsatfda_docs/label/2009/021529s004lbl.pdf.
   Google Scholar
• Bayer HealthCare Pharmaceuticals. Mirena (levonorgestrel-releasing intrauterine system); 2017 [cited 2020 Jan 12]. Available from: https://labeling.bayerhealthcare.com/html/products/pi/Mirena_PI.pdf.
   Google Scholar
• Bennink HJ. The pharmacokinetics and pharmacodynamics of Implanon, a single-rod etonogestrel contraceptive implant. Eur J Contracept Reprod Health Care. 2000;5:12–20.
   PubMedGoogle Scholar
• Apter D, Gemzell-Danielsson K, Hauck B, et al. Pharmacokinetics of two low-dose levonorgestrel-releasing intrauterine systems and effects on ovulation rate and cervical function: pooled analyses of phase II and III studies. Fertil Steril. 2014;101:1656–1662.e1-4.
   PubMed Web of Science ®Google Scholar
• Yucel N, Baskent E, Karamustafaoglu Balci B, et al. The levonorgestrel-releasing intrauterine system is associated with a reduction in dysmenorrhoea and dyspareunia, a decrease in CA 125 levels, and an increase in quality of life in women with suspected endometriosis. Aust N Z J Obstet Gynaecol. 2018;58:560–563.
   PubMed Web of Science ®Google Scholar
• Schulz KF, Grimes DA. Sample size calculations in randomised trials: mandatory and mystical. Lancet. 2005;365:1348–1353.
   PubMed Web of Science ®Google Scholar
• Vercellini P, Frontino G, De Giorgi O, et al. Comparison of a levonorgestrel-releasing intrauterine device versus expectant management after conservative surgery for symptomatic endometriosis: a pilot study. Fertil Steril. 2003;80:305–309.
   PubMed Web of Science ®Google Scholar